Isao Tsuboi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Isao Tsuboi has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
Shin Aizawa
Division of Anatomical Science, Department of Functional Morphology, Nihon University School of Medicine, 30-1 Ohyaguchi-kami-machi, Itabashi-ku, Tokyo, 173-8610, Japan
8 shared publicationsTomonori Harada
Division of Anatomical Science, Department of Functional Morphology, Nihon University School of Medicine, 30-1 Ohyaguchi-kami-machi, Itabashi-ku, Tokyo, 173-8610, Japan
6 shared publicationsMichiko Naito
Nihon University School of Medicine
3 shared publicationsTohru Inoue
Nihon University School of Medicine
3 shared publications- Tomonori Harada
Division of Anatomical Science, Department of Functional Morphology, Nihon University School of Medicine
3 shared publications Yoko Hirabayashi
Center for Biological Safety and Research, National Institute of Health Sciences, Kawasaki, Japan
3 shared publications
Latest Publications
- 1 December 2020
- Published by Elsevier in Journal of Bioscience and Bioengineering
- Vol. 130 (6) , 650-658
Kinetics of leukemic cells in 3D culture with stromal cells and with arginine deprivation stress
- 1 December 2020
- Published by Elsevier in Journal of Bioscience and Bioengineering
- Vol. 130 (6) , 650-658
Kinetics of leukemic cells in 3D culture with stromal cells and with arginine deprivation stress
- 6 June 2020
- Published by Springer Nature in Annals of Hematology
- Vol. 99 (7) , 1515-1523
Dynamics of hematopoiesis is disrupted by impaired hematopoietic microenvironment in a mouse model of hemophagocytic lymphohistiocytosis
Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening systemic hyperinflammatory disorder. We found recently that repeated lipopolysaccharide (LPS) treatment induces HLH-like features in senescence-accelerated mice (SAMP1/TA-1) but not in senescence-resistant control mice (SAMR1). In this study, we analyzed the dynamics of hematopoiesis in this mouse model of HLH. When treated repeatedly with LPS, the numbers of myeloid progenitor cells (CFU-GM) and B-lymphoid progenitor cells (CFU-preB) in the bone marrow (BM) rapidly decreased after each treatment in both strains. The number of CFU-GM in SAMP1/TA-1 and SAMR1, and of CFU-preB in SAMR1, returned to pretreatment levels by 7 days after each treatment. However, the recovery in the number of CFU-preB in SAMP1/TA-1 was limited. In both strains, the BM expression of genes encoding positive regulators of myelopoiesis (granulocyte colony-stimulating factor (G-CSF), granulocyte macrophage colony-stimulating factor (GM-CSF), and interleukin (IL)-6), and negative regulators of B lymphopoiesis (tumor necrosis factor (TNF)-α) was increased. The expression of genes encoding positive regulators of B lymphopoiesis (stromal-cell derived factor (SDF)-1, IL-7, and stem cell factor (SCF)) was persistently decreased in SAMP1/TA-1 but not in SAMR1. Expression of the gene encoding p16INK4a and the proportion of β-galactosidase-positive cells were increased in cultured stromal cells obtained from LPS-treated SAMP1/TA-1 but not in those from LPS-treated SAMR1. LPS treatment induced qualitative changes in stromal cells, which comprise the microenvironment supporting appropriate hematopoiesis, in SAMP1/TA-1; these stromal cell changes are inferred to disrupt the dynamics of hematopoiesis. Thus, hematopoietic tissue is one of the organs that suffer life-threatening damage in HLH.
- 6 June 2020
- Published by Springer Nature in Annals of Hematology
- Vol. 99 (7) , 1515-1523
Dynamics of hematopoiesis is disrupted by impaired hematopoietic microenvironment in a mouse model of hemophagocytic lymphohistiocytosis
Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening systemic hyperinflammatory disorder. We found recently that repeated lipopolysaccharide (LPS) treatment induces HLH-like features in senescence-accelerated mice (SAMP1/TA-1) but not in senescence-resistant control mice (SAMR1). In this study, we analyzed the dynamics of hematopoiesis in this mouse model of HLH. When treated repeatedly with LPS, the numbers of myeloid progenitor cells (CFU-GM) and B-lymphoid progenitor cells (CFU-preB) in the bone marrow (BM) rapidly decreased after each treatment in both strains. The number of CFU-GM in SAMP1/TA-1 and SAMR1, and of CFU-preB in SAMR1, returned to pretreatment levels by 7 days after each treatment. However, the recovery in the number of CFU-preB in SAMP1/TA-1 was limited. In both strains, the BM expression of genes encoding positive regulators of myelopoiesis (granulocyte colony-stimulating factor (G-CSF), granulocyte macrophage colony-stimulating factor (GM-CSF), and interleukin (IL)-6), and negative regulators of B lymphopoiesis (tumor necrosis factor (TNF)-α) was increased. The expression of genes encoding positive regulators of B lymphopoiesis (stromal-cell derived factor (SDF)-1, IL-7, and stem cell factor (SCF)) was persistently decreased in SAMP1/TA-1 but not in SAMR1. Expression of the gene encoding p16INK4a and the proportion of β-galactosidase-positive cells were increased in cultured stromal cells obtained from LPS-treated SAMP1/TA-1 but not in those from LPS-treated SAMR1. LPS treatment induced qualitative changes in stromal cells, which comprise the microenvironment supporting appropriate hematopoiesis, in SAMP1/TA-1; these stromal cell changes are inferred to disrupt the dynamics of hematopoiesis. Thus, hematopoietic tissue is one of the organs that suffer life-threatening damage in HLH.
- Open Access
- 28 February 2019
- Published by Ferrata Storti Foundation (Haematologica) in Haematologica
- Vol. 104 (10) , 1995-2005
Senescence-accelerated mice (SAMP1/TA-1) treated repeatedly with lipopolysaccharide develop a condition that resembles hemophagocytic lymphohistiocytosis
Hemophagocytic lymphohistiocytosis is a life-threatening systemic hyperinflammatory disorder with primary and secondary forms. Primary hemophagocytic lymphohistiocytosis is associated with inherited defects in various genes that affect the immunological cytolytic pathway. Secondary hemophagocytic lymphohistiocytosis is not inherited, but complicates various medical conditions including infection, autoinflammatory/autoimmune disease, and malignant disease. When senescence-accelerated mice (SAMP1/TA-1) with latent deterioration of immunological function and senescence-resistant control mice (SAMR1) were treated repeatedly with lipopolysaccharide, SAMP1/TA-1 mice displayed the clinicopathological features of hemophagocytic lymphohistiocytosis such as hepatosplenomegaly, pancytopenia, hypofibrinogenemia, hyperferritinemia, and hemophagocytosis. SAMR1 mice showed no features of hemophagocytic lymphohistiocytosis. Lipopolysaccharide induced up-regulation of proinflammatory cytokines such as interleukin-1β, interleukin-6, tumor necrosis factor-α, and interferon-γ, and interferon-γ-inducible chemokines such as c-x-c motif chemokine ligand 9 and 10 in the liver and spleen in both SAMP1/TA-1 and SAMR1 mice. However, up-regulation of proinflammatory cytokines and interferon-γ-inducible chemokines in the liver of SAMP1/TA-1 mice was prolonged compared with that in SAMR1 mice. In addition, the magnitude of up-regulation of interferon-γ in the liver and spleen after lipopolysaccharide treatment was greater in SAMP1/TA-1 mice than in SAMR1 mice. Furthermore, lipopolysaccharide treatment led to a prolonged increase in the proportion of peritoneal M1 macrophages and simultaneously to a decrease in the proportion of M2 macrophages in SAMP1/TA-1 mice compared with SAMR1 mice. Lipopolysaccharide appeared to induce a hyperinflammatory reaction and prolonged inflammation in SAMP1/TA-1 mice, resulting in the features of secondary hemophagocytic lymphohistiocytosis. Thus, SAMP1/TA-1 mice represent a useful mouse model to investigate the pathogenesis of bacterial infection-associated secondary hemophagocytic lymphohistiocytosis.
- 28 February 2019
- Published by Ferrata Storti Foundation (Haematologica) in Haematologica
- Vol. 104 (10) , 1995-2005
Open AccessSenescence-accelerated mice (SAMP1/TA-1) treated repeatedly with lipopolysaccharide develop a condition that resembles hemophagocytic lymphohistiocytosis
Hemophagocytic lymphohistiocytosis is a life-threatening systemic hyperinflammatory disorder with primary and secondary forms. Primary hemophagocytic lymphohistiocytosis is associated with inherited defects in various genes that affect the immunological cytolytic pathway. Secondary hemophagocytic lymphohistiocytosis is not inherited, but complicates various medical conditions including infection, autoinflammatory/autoimmune disease, and malignant disease. When senescence-accelerated mice (SAMP1/TA-1) with latent deterioration of immunological function and senescence-resistant control mice (SAMR1) were treated repeatedly with lipopolysaccharide, SAMP1/TA-1 mice displayed the clinicopathological features of hemophagocytic lymphohistiocytosis such as hepatosplenomegaly, pancytopenia, hypofibrinogenemia, hyperferritinemia, and hemophagocytosis. SAMR1 mice showed no features of hemophagocytic lymphohistiocytosis. Lipopolysaccharide induced up-regulation of proinflammatory cytokines such as interleukin-1β, interleukin-6, tumor necrosis factor-α, and interferon-γ, and interferon-γ-inducible chemokines such as c-x-c motif chemokine ligand 9 and 10 in the liver and spleen in both SAMP1/TA-1 and SAMR1 mice. However, up-regulation of proinflammatory cytokines and interferon-γ-inducible chemokines in the liver of SAMP1/TA-1 mice was prolonged compared with that in SAMR1 mice. In addition, the magnitude of up-regulation of interferon-γ in the liver and spleen after lipopolysaccharide treatment was greater in SAMP1/TA-1 mice than in SAMR1 mice. Furthermore, lipopolysaccharide treatment led to a prolonged increase in the proportion of peritoneal M1 macrophages and simultaneously to a decrease in the proportion of M2 macrophages in SAMP1/TA-1 mice compared with SAMR1 mice. Lipopolysaccharide appeared to induce a hyperinflammatory reaction and prolonged inflammation in SAMP1/TA-1 mice, resulting in the features of secondary hemophagocytic lymphohistiocytosis. Thus, SAMP1/TA-1 mice represent a useful mouse model to investigate the pathogenesis of bacterial infection-associated secondary hemophagocytic lymphohistiocytosis.
- Open Access
- 1 January 2016
- Published by Pharmaceutical Society of Japan in Biological and Pharmaceutical Bulletin
- Vol. 39 (12) , 1939-1947
Differential Regulation of Lympho-Myelopoiesis by Stromal Cells in the Early and Late Phases in BALB/c Mice Repeatedly Exposed to Lipopolysaccharide
Chronic lipopolysaccharide (LPS) exposure to mice reduces the lymphoid compartment and skews the hematopoietic cell compartment toward myeloid-cells, which is considered to be a direct effect of LPS on hematopoietic stem cells. However, the effect of chronic LPS exposure on stromal-cells, which compose the hematopoietic microenvironment, has not been elucidated. Here, we investigated early- and late-phase effects of repeated LPS exposure on stromal-cells. During the early phase, when mice were treated with 5 or 25 µg LPS three times at weekly intervals, the numbers of myeloid-progenitor (colony forming unit-granulocyte macrophage (CFU-GM)) cells and B lymphoid-progenitor (CFU-preB) cells in the bone-marrow (BM) rapidly decreased after each treatment. The number of CFU-GM cells recovered from the initial decrease and then increased to levels higher than pretreatment levels, whereas the number of CFU-preB cells remained lower than pretreatment levels. In the BM, expression of genes for positive-regulators of myelopoiesis including granulocyte colony-stimulating factor (G-CSF), granulocyte macrophage colony-stimulating factor (GM-CSF), and interleukin (IL)-6 and negative-regulators of B lymphopoiesis including tumor necrosis factor (TNF)-α was up-regulated, whereas expression of positive-regulators of B lymphopoiesis including stromal cell-derived factor (SDF)-1, IL-7, and stem cell factor (SCF) was down-regulated. During the late phase, the number of CFU-preB cells remained lower than pretreatment levels 70 d after the first treatments with 5 and 25 µg LPS, whereas the number of CFU-GM cells returned to pretreatment levels. IL-7 gene expression in the BM remained down-regulated, whereas gene-expression levels of SDF-1 and SCF were restored. Thus, chronic LPS exposure may impair stromal-cell function, resulting in prolonged suppression of B lymphopoiesis, which may appear to be senescence similar to the hematological phenotype.
- 1 January 2016
- Published by Pharmaceutical Society of Japan in Biological and Pharmaceutical Bulletin
- Vol. 39 (12) , 1939-1947
Open AccessDifferential Regulation of Lympho-Myelopoiesis by Stromal Cells in the Early and Late Phases in BALB/c Mice Repeatedly Exposed to Lipopolysaccharide
Chronic lipopolysaccharide (LPS) exposure to mice reduces the lymphoid compartment and skews the hematopoietic cell compartment toward myeloid-cells, which is considered to be a direct effect of LPS on hematopoietic stem cells. However, the effect of chronic LPS exposure on stromal-cells, which compose the hematopoietic microenvironment, has not been elucidated. Here, we investigated early- and late-phase effects of repeated LPS exposure on stromal-cells. During the early phase, when mice were treated with 5 or 25 µg LPS three times at weekly intervals, the numbers of myeloid-progenitor (colony forming unit-granulocyte macrophage (CFU-GM)) cells and B lymphoid-progenitor (CFU-preB) cells in the bone-marrow (BM) rapidly decreased after each treatment. The number of CFU-GM cells recovered from the initial decrease and then increased to levels higher than pretreatment levels, whereas the number of CFU-preB cells remained lower than pretreatment levels. In the BM, expression of genes for positive-regulators of myelopoiesis including granulocyte colony-stimulating factor (G-CSF), granulocyte macrophage colony-stimulating factor (GM-CSF), and interleukin (IL)-6 and negative-regulators of B lymphopoiesis including tumor necrosis factor (TNF)-α was up-regulated, whereas expression of positive-regulators of B lymphopoiesis including stromal cell-derived factor (SDF)-1, IL-7, and stem cell factor (SCF) was down-regulated. During the late phase, the number of CFU-preB cells remained lower than pretreatment levels 70 d after the first treatments with 5 and 25 µg LPS, whereas the number of CFU-GM cells returned to pretreatment levels. IL-7 gene expression in the BM remained down-regulated, whereas gene-expression levels of SDF-1 and SCF were restored. Thus, chronic LPS exposure may impair stromal-cell function, resulting in prolonged suppression of B lymphopoiesis, which may appear to be senescence similar to the hematological phenotype.
- Open Access
- 1 January 2016
- Published by The Japanese Society of Physical Fitness and Sports Medicine in The Journal of Physical Fitness and Sports Medicine
- Vol. 5 (2) , 167-175
Age-related functional changes in hematopoietic microenvironment
The hematopoietic microenvironment composed of stromal cells strictly regulates hematopoietic stem cells and hematopoietic progenitor cells by producing positive-and negative-regulators to supply mature hematopoietic cells to the periphery throughout its entire lifetime. However, hematopoiesis attenuates with aging. Extensive studies have revealed cellintrinsic deterioration of hematopoietic cells with aging, but the responsibility of the age-associated deterioration of stromal cells has not yet been fully elucidated. Senescence-accelerated mice (SAMP1) exhibited premature senescence-like stromal cell impairment after 30 weeks of age. Thus, this model mouse is a useful tool for clarifying the role of stromal cells during the development of senescence-associated defects in hematopoiesis. It is well known that B lymphopoiesis at steady-state is attenuated with aging, whereas myelopoiesis remains unaffected. At steady-state, SAMP1 mice exhibit simultaneous down-regulation of positive-and negative-regulators of B lymphopoiesis in the bone marrow during premature aging, resulting in suppressive homeostasis in B cell development. While both regulators are down-regulated, the relative cytokine levels are barely maintained at a steady-state. Once SAMP1 mice are in a perturbed condition induced by myeloablation or inflammation, the latent deterioration of stromal cell function becomes apparent in aged mice: they exhibit dysregulation of positive and negative regulators produced by stromal cells, resulting in decreased supportive activity for not only B lymphopoiesis, but also for the hematopoiesis of other lineages, such as myelopoiesis, erythropoiesis and mast cell development. These results suggest that the age-associated deterioration of hematopoiesis may be due not only to hematopoietic cell-intrinsic deterioration, but also to hematopoietic cell-extrinsic deterioration, such as stromal cell deterioration.
- 1 January 2016
- Published by The Japanese Society of Physical Fitness and Sports Medicine in The Journal of Physical Fitness and Sports Medicine
- Vol. 5 (2) , 167-175
Open AccessAge-related functional changes in hematopoietic microenvironment
The hematopoietic microenvironment composed of stromal cells strictly regulates hematopoietic stem cells and hematopoietic progenitor cells by producing positive-and negative-regulators to supply mature hematopoietic cells to the periphery throughout its entire lifetime. However, hematopoiesis attenuates with aging. Extensive studies have revealed cellintrinsic deterioration of hematopoietic cells with aging, but the responsibility of the age-associated deterioration of stromal cells has not yet been fully elucidated. Senescence-accelerated mice (SAMP1) exhibited premature senescence-like stromal cell impairment after 30 weeks of age. Thus, this model mouse is a useful tool for clarifying the role of stromal cells during the development of senescence-associated defects in hematopoiesis. It is well known that B lymphopoiesis at steady-state is attenuated with aging, whereas myelopoiesis remains unaffected. At steady-state, SAMP1 mice exhibit simultaneous down-regulation of positive-and negative-regulators of B lymphopoiesis in the bone marrow during premature aging, resulting in suppressive homeostasis in B cell development. While both regulators are down-regulated, the relative cytokine levels are barely maintained at a steady-state. Once SAMP1 mice are in a perturbed condition induced by myeloablation or inflammation, the latent deterioration of stromal cell function becomes apparent in aged mice: they exhibit dysregulation of positive and negative regulators produced by stromal cells, resulting in decreased supportive activity for not only B lymphopoiesis, but also for the hematopoiesis of other lineages, such as myelopoiesis, erythropoiesis and mast cell development. These results suggest that the age-associated deterioration of hematopoiesis may be due not only to hematopoietic cell-intrinsic deterioration, but also to hematopoietic cell-extrinsic deterioration, such as stromal cell deterioration.
- 24 October 2015
- Published by Springer Nature in Anatomical Science International
- Vol. 91 (4) , 419-422
A case of a quadricuspid pulmonary valve in a Japanese female
A supernumerary cusp of the pulmonary valve was incidentally found in an 88-year-old Japanese female during a gross anatomy course. The valve was composed of three equal-sized leaflets and one smaller leaflet. The supernumerary leaflet was located between the anterior and right semilunar leaflets. This pulmonary valve consisted of four pulmonary aortic bulbs. The donated body was a female who had a past history of myocardial infarction and was diagnosed as having ischemic heart disease at the last admission. Tricuspid valve regurgitation and pulmonary hypertension were diagnosed on echocardiography. These findings were considered to have been caused by left heart failure and not by the quadricuspid pulmonary valve. This asymptomatic anatomical variation might have developed from a protrusion between the anterior and right swelling of the outflow tract during semilunar valve development.
- 24 October 2015
- Published by Springer Nature in Anatomical Science International
- Vol. 91 (4) , 419-422
A case of a quadricuspid pulmonary valve in a Japanese female
A supernumerary cusp of the pulmonary valve was incidentally found in an 88-year-old Japanese female during a gross anatomy course. The valve was composed of three equal-sized leaflets and one smaller leaflet. The supernumerary leaflet was located between the anterior and right semilunar leaflets. This pulmonary valve consisted of four pulmonary aortic bulbs. The donated body was a female who had a past history of myocardial infarction and was diagnosed as having ischemic heart disease at the last admission. Tricuspid valve regurgitation and pulmonary hypertension were diagnosed on echocardiography. These findings were considered to have been caused by left heart failure and not by the quadricuspid pulmonary valve. This asymptomatic anatomical variation might have developed from a protrusion between the anterior and right swelling of the outflow tract during semilunar valve development.
- 13 June 2014
- Published by Springer Nature in Clinical and Experimental Medicine
- Vol. 15 (2) , 179-188
Decreased “ineffective erythropoiesis” preserves polycythemia in mice under long-term hypoxia
Hypoxia induces innumerable changes in humans and other animals, including an increase in peripheral red blood cells (polycythemia) caused by the activation of erythropoiesis mediated by increased erythropoietin (EPO) production. However, the elevation of EPO is limited and levels return to normal ranges under normoxia within 5–7 days of exposure to hypoxia, whereas polycythemia continues for as long as hypoxia persists. We investigated erythropoiesis in bone marrow and spleens from mouse models of long-term normobaric hypoxia (10 % O2) to clarify the mechanism of prolonged polycythemia in chronic hypoxia. The numbers of erythroid colony-forming units (CFU-E) in the spleen remarkably increased along with elevated serum EPO levels indicating the activation of erythropoiesis during the first 7 days of hypoxia. After 14 days of hypoxia, the numbers of CFU-E returned to normoxic levels, whereas polycythemia persisted for >140 days. Flow cytometry revealed a prolonged increase in the numbers of TER119-positive cells (erythroid cells derived from pro-erythroblasts through mature erythrocyte stages), especially the TER119 (high) CD71 (high) population, in bone marrow. The numbers of annexin-V-positive cells among the TER119-positive cells particularly declined under chronic hypoxia, suggesting that the numbers of apoptotic cells decrease during erythroid cell maturation. Furthermore, RT-PCR analysis showed that the RNA expression of BMP-4 and stem cell factor that reduces apoptotic changes during erythroid cell proliferation and maturation was increased in bone marrow under hypoxia. These findings indicated that decreased apoptosis of erythroid cells during erythropoiesis contributes to polycythemia in mice during chronic exposure to long-term hypoxia.
- 13 June 2014
- Published by Springer Nature in Clinical and Experimental Medicine
- Vol. 15 (2) , 179-188
Decreased “ineffective erythropoiesis” preserves polycythemia in mice under long-term hypoxia
Hypoxia induces innumerable changes in humans and other animals, including an increase in peripheral red blood cells (polycythemia) caused by the activation of erythropoiesis mediated by increased erythropoietin (EPO) production. However, the elevation of EPO is limited and levels return to normal ranges under normoxia within 5–7 days of exposure to hypoxia, whereas polycythemia continues for as long as hypoxia persists. We investigated erythropoiesis in bone marrow and spleens from mouse models of long-term normobaric hypoxia (10 % O2) to clarify the mechanism of prolonged polycythemia in chronic hypoxia. The numbers of erythroid colony-forming units (CFU-E) in the spleen remarkably increased along with elevated serum EPO levels indicating the activation of erythropoiesis during the first 7 days of hypoxia. After 14 days of hypoxia, the numbers of CFU-E returned to normoxic levels, whereas polycythemia persisted for >140 days. Flow cytometry revealed a prolonged increase in the numbers of TER119-positive cells (erythroid cells derived from pro-erythroblasts through mature erythrocyte stages), especially the TER119 (high) CD71 (high) population, in bone marrow. The numbers of annexin-V-positive cells among the TER119-positive cells particularly declined under chronic hypoxia, suggesting that the numbers of apoptotic cells decrease during erythroid cell maturation. Furthermore, RT-PCR analysis showed that the RNA expression of BMP-4 and stem cell factor that reduces apoptotic changes during erythroid cell proliferation and maturation was increased in bone marrow under hypoxia. These findings indicated that decreased apoptosis of erythroid cells during erythropoiesis contributes to polycythemia in mice during chronic exposure to long-term hypoxia.
- Open Access
- 1 January 2014
- Published by Pharmaceutical Society of Japan in Biological and Pharmaceutical Bulletin
- Vol. 37 (12) , 1872-1881
Lipopolysaccharide Reciprocally Alters the Stromal Cell-Regulated Positive and Negative Balance between Myelopoiesis and B Lymphopoiesis in C57BL/6 Mice
Hematopoiesis in the bone marrow (BM) and spleen is controlled by stromal cells. Inflammation promotes myelopoiesis and simultaneously suppresses B lymphopoiesis. However, the role of the reciprocal regulation of myelopoiesis and B lymphopoiesis by stromal cells during inflammation is not fully understood. We investigated inflammation-induced alteration of hematopoietic regulation in lipopolysaccharide (LPS)-treated mice. C57BL/6 female mice were intravenously injected with a single, 5-µg dose of LPS, which induced a rapid decrease in the number of granulocyte-macrophage progenitors (colony-forming unit granulocyte-macrophage; CFU-GM) and B cell progenitors (CFU-preB) in BM. The CFU-GM count rapidly recovered, whereas the recovery of CFU-preB was delayed. LPS induced a marked increase in the number of CFU-GM but not in the number of CFU-preB in spleen. After LPS treatment, gene expression levels of positive regulators of myelopoiesis such as granulocyte colony-stimulating factor (G-CSF), interleukin (IL)-6, and granulocyte-macrophage colony-stimulating factor (GM-CSF) in BM and spleen were markedly upregulated whereas levels of positive regulators for B lymphopoiesis such as stromal cell-derived factor (SDF)-1, stem cell factor (SCF), and IL-7 remained unchanged. Meanwhile, the negative regulator of B lymphopoiesis tumor necrosis factor (TNF)-α was markedly up-regulated. The number of CFU-GM in S-phase in BM increased after LPS treatment, whereas the number of CFU-preB in S-phase decreased. These results suggest that LPS-activated stromal cells induce positive-dominant regulation of myelopoiesis and negative-dominant regulation of B lymphopoiesis, which facilitates emergency myelopoiesis during inflammation by suppressing B lymphopoiesis, thereby contributing to the host defense against infection.
- 1 January 2014
- Published by Pharmaceutical Society of Japan in Biological and Pharmaceutical Bulletin
- Vol. 37 (12) , 1872-1881
Open AccessLipopolysaccharide Reciprocally Alters the Stromal Cell-Regulated Positive and Negative Balance between Myelopoiesis and B Lymphopoiesis in C57BL/6 Mice
Hematopoiesis in the bone marrow (BM) and spleen is controlled by stromal cells. Inflammation promotes myelopoiesis and simultaneously suppresses B lymphopoiesis. However, the role of the reciprocal regulation of myelopoiesis and B lymphopoiesis by stromal cells during inflammation is not fully understood. We investigated inflammation-induced alteration of hematopoietic regulation in lipopolysaccharide (LPS)-treated mice. C57BL/6 female mice were intravenously injected with a single, 5-µg dose of LPS, which induced a rapid decrease in the number of granulocyte-macrophage progenitors (colony-forming unit granulocyte-macrophage; CFU-GM) and B cell progenitors (CFU-preB) in BM. The CFU-GM count rapidly recovered, whereas the recovery of CFU-preB was delayed. LPS induced a marked increase in the number of CFU-GM but not in the number of CFU-preB in spleen. After LPS treatment, gene expression levels of positive regulators of myelopoiesis such as granulocyte colony-stimulating factor (G-CSF), interleukin (IL)-6, and granulocyte-macrophage colony-stimulating factor (GM-CSF) in BM and spleen were markedly upregulated whereas levels of positive regulators for B lymphopoiesis such as stromal cell-derived factor (SDF)-1, stem cell factor (SCF), and IL-7 remained unchanged. Meanwhile, the negative regulator of B lymphopoiesis tumor necrosis factor (TNF)-α was markedly up-regulated. The number of CFU-GM in S-phase in BM increased after LPS treatment, whereas the number of CFU-preB in S-phase decreased. These results suggest that LPS-activated stromal cells induce positive-dominant regulation of myelopoiesis and negative-dominant regulation of B lymphopoiesis, which facilitates emergency myelopoiesis during inflammation by suppressing B lymphopoiesis, thereby contributing to the host defense against infection.
- 14 March 2008
- Published by Wiley in Journal of Applied Toxicology
- Vol. 28 (6) , 797-805
Role of hematopoietic microenvironment in prolonged impairment of B cell regeneration in age‐related stromal‐cell‐impaired SAMP1 mouse: effects of a single dose of 5‐fluorouracil
In this study, we examined the age‐associated defect of stromal cells, which support B cell development, treated with 5‐fluorouracil (5‐FU) to induce severe perturbation of hematopoiesis, including B lymphocyte development, using SAMP1 mice exhibiting senescence‐mimicking stromal‐cell impairment after 30 weeks of age. Significant findings of this study are as follows: first, a marked and prolonged decrease in number of CFU‐preB cells in non‐SCI mice (58% of the steady‐state level) associated with more markedly depressed number of CFU‐preB cells in SCI mice (20% of the steady‐state level), despite the absence of difference in the number of CFU‐GMs during the period; second, in the non‐SCI mice, a significant and prolonged up‐regulation of GM‐CSF and IL‐6, positive regulators of myelopoiesis and suppressive factors of B lymphopoiesis, was observed. In SCI mice, greater and prolonged suppression of B lymphopoiesis was clearly demonstrated by the significant up‐regulation of the negative regulator TNF‐α associated with the concomitant marked down‐regulation of the positive regulator SDF‐1, although the increases of GM‐CSF and IL‐6 were limited. That is, ‘negative complementation’ makes preB recovery after 5‐FU treatment impaired and prolonged. Principal component analysis clearly showed differences in the cytokine expression patterns in both early and later phases and the time course of the expression pattern of each cytokine between SCI and non‐SCI mice without supervising information. An impaired regulation of the expressions of not only positive but also negative regulators after 5‐FU treatment was, in part, the cause of the impaired regeneration of CFU‐preB cells in SCI mice. Copyright © 2008 John Wiley & Sons, Ltd.
- 14 March 2008
- Published by Wiley in Journal of Applied Toxicology
- Vol. 28 (6) , 797-805
Role of hematopoietic microenvironment in prolonged impairment of B cell regeneration in age‐related stromal‐cell‐impaired SAMP1 mouse: effects of a single dose of 5‐fluorouracil
In this study, we examined the age‐associated defect of stromal cells, which support B cell development, treated with 5‐fluorouracil (5‐FU) to induce severe perturbation of hematopoiesis, including B lymphocyte development, using SAMP1 mice exhibiting senescence‐mimicking stromal‐cell impairment after 30 weeks of age. Significant findings of this study are as follows: first, a marked and prolonged decrease in number of CFU‐preB cells in non‐SCI mice (58% of the steady‐state level) associated with more markedly depressed number of CFU‐preB cells in SCI mice (20% of the steady‐state level), despite the absence of difference in the number of CFU‐GMs during the period; second, in the non‐SCI mice, a significant and prolonged up‐regulation of GM‐CSF and IL‐6, positive regulators of myelopoiesis and suppressive factors of B lymphopoiesis, was observed. In SCI mice, greater and prolonged suppression of B lymphopoiesis was clearly demonstrated by the significant up‐regulation of the negative regulator TNF‐α associated with the concomitant marked down‐regulation of the positive regulator SDF‐1, although the increases of GM‐CSF and IL‐6 were limited. That is, ‘negative complementation’ makes preB recovery after 5‐FU treatment impaired and prolonged. Principal component analysis clearly showed differences in the cytokine expression patterns in both early and later phases and the time course of the expression pattern of each cytokine between SCI and non‐SCI mice without supervising information. An impaired regulation of the expressions of not only positive but also negative regulators after 5‐FU treatment was, in part, the cause of the impaired regeneration of CFU‐preB cells in SCI mice. Copyright © 2008 John Wiley & Sons, Ltd.